Q1 Revenue Declines 35% to $433K, Net Loss Narrows, Going Concern Alleviated with $5M Credit Line Extension
Summary
NutriBand Inc. reported a 35.1% revenue decline in Q1, but reduced its net loss and cash burn, and extended a $5 million credit line, alleviating going concern doubts.
Key Events
-
Q1 Revenue Decline
Revenue for the three months ended April 30, 2026, decreased by 35.1% year-over-year to $433,399 from $667,432 in the prior year period. This decline was primarily due to a key contract manufacturing customer moving operations to Asia.
-
Net Loss Narrows & Cash Burn Improves
The company reported a net loss of $(1,241,956) for the quarter, an improvement from $(1,388,869) in the same period last year. Cash used in operating activities significantly decreased to $(563,104) from $(1,336,972) year-over-year.
-
Going Concern Alleviated
Management believes that sufficient funds will be generated from operations and available financing to fund operations for at least one year, alleviating substantial doubt about the company's ability to continue as a going concern.
-
$5 Million Credit Line Extended
Subsequent to the quarter end, on June 1, 2026, the company extended its $5 million credit line facility with TII Jet Services to June 30, 2029. No amounts are currently drawn under this facility.
Analysis
NutriBand Inc. reported a significant 35.1% year-over-year revenue decline for its first fiscal quarter, which is a notable negative. However, the company successfully narrowed its net loss and substantially reduced its cash burn from operations. Crucially, management has alleviated the 'going concern' doubt, supported by the extension of a $5 million credit line until June 2029. For a micro-cap company, securing this financing and removing the going concern uncertainty are critical for its operational runway and future development, outweighing the revenue dip.
At the time of this filing, NTRB was trading at $3.52 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $42.8M. The 52-week trading range was $3.21 to $11.68. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.